Recent studies show that COL4A1 expression is upregulated by the transcription factor RUNX1 and found that HCC cells with high COL4A1 expression are sensitive to the treatment of FAK or Src inhibitors. This evidence concerns the gene COL4A1 and hepatocellular carcinoma.